Akero Therapeutics, Inc.
Akero Therapeutics, Inc.（AKRO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
akro · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年2月3日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$56.00
Consensus
$48.40
-11.4% upside
Low
$38.00
Median: $54 · Last Close: $54.65
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$48.40
-11.4% upside
High Target
$56
2.5%
Low Target
$38
-30.5%
Current Price
$54.65
as of today
Based on analyst price targets, the AKRO stock price prediction for the next 12 months ranges from $38 to $56. The consensus AKRO price forecast of $48.40 implies -11.4% upside from the current price of $54.65.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $54.76 | ↑ 0.20% |
1-day model range: $54.74–$54.78. Peak: $54.78 (+0.20%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AKRO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-10-10 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2025-10-10 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-09 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-10-09 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2025-05-27 | B of A Securities | Maintains | Buy→Buy |
| 2025-05-13 | Citigroup | Maintains | Buy→Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-31 | UBS | Maintains | Buy→Buy |
| 2025-01-30 | B of A Securities | Upgrade ↑ | Neutral→Buy |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Akero Therapeutics, Inc. (AKRO) stock. Of the recent 63 rating actions, 3 were upgrades and 5 were downgrades. 14 analysts currently cover AKRO.
分析师推荐趋势
AKRO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$3M
EPS This Year
$-3.82
EPS Next Year
$-4.31
↑ 13.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast AKRO EPS of $-3.82 for the current fiscal year, based on estimates from 4 analysts. The AKRO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AKRO 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AKRO 的共识目标价为 $48.40（-11.4% 上行空间），分析师共识为 Buy。
AKRO 的短期预测（明日）为 $54.76（+0.20%）。
Akero Therapeutics, Inc. 在 NASDAQ 上市，代码 AKRO。AKRO 在 2027 年的整体展望偏积极，在覆盖分析师中约 71% 对应 Buy 共识。
常见问题
AKRO 预测 · 8 个问题根据 14 位华尔街分析师，AKRO 的 12 个月平均目标价为 $48.40，最高 $56.00、最低 $38.00。若有图表，中位目标价可在上方查看。相对当前价 $54.65，隐含约 -11.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.